Maccura Biotechnology Co Ltd (300463) - Total Liabilities
Based on the latest financial reports, Maccura Biotechnology Co Ltd (300463) has total liabilities worth CN¥1.48 Billion CNY (≈ $217.25 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Maccura Biotechnology Co Ltd to see how much of total assets are deployed in long-term investments.
Maccura Biotechnology Co Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Maccura Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Maccura Biotechnology Co Ltd's balance sheet.
Maccura Biotechnology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Maccura Biotechnology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lincoln Educational Services
NASDAQ:LINC
|
USA | $293.48 Million |
|
UniTTEC Co Ltd
SHE:000925
|
China | CN¥5.45 Billion |
|
Synsam AB
ST:SYNSAM
|
Sweden | Skr5.83 Billion |
|
Shanghai Haohai Biological Tech Co
SHG:688366
|
China | CN¥1.23 Billion |
|
Carlyle Secured Lending Inc
NASDAQ:CGBD
|
USA | $1.62 Billion |
|
Sichuan Chuanhuan Technology Co Ltd
SHE:300547
|
China | CN¥385.84 Million |
|
RHOEN-KLINIK.UNSP.ADR 1/2
F:RHKU
|
Germany | €523.09 Million |
|
Sanjiang Shopping Club Co Ltd
SHG:601116
|
China | CN¥1.73 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Maccura Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Maccura Biotechnology Co Ltd (300463) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.99 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Maccura Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Maccura Biotechnology Co Ltd (2011–2025)
The table below shows the annual total liabilities of Maccura Biotechnology Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.69 Billion ≈ $247.14 Million |
+8.78% |
| 2024-12-31 | CN¥1.55 Billion ≈ $227.20 Million |
+2.98% |
| 2023-12-31 | CN¥1.51 Billion ≈ $220.64 Million |
-7.62% |
| 2022-12-31 | CN¥1.63 Billion ≈ $238.84 Million |
-19.40% |
| 2021-12-31 | CN¥2.03 Billion ≈ $296.35 Million |
-14.17% |
| 2020-12-31 | CN¥2.36 Billion ≈ $345.27 Million |
+8.77% |
| 2019-12-31 | CN¥2.17 Billion ≈ $317.42 Million |
+28.24% |
| 2018-12-31 | CN¥1.69 Billion ≈ $247.52 Million |
+74.36% |
| 2017-12-31 | CN¥970.12 Million ≈ $141.96 Million |
+133.76% |
| 2016-12-31 | CN¥415.01 Million ≈ $60.73 Million |
+11.65% |
| 2015-12-31 | CN¥371.71 Million ≈ $54.39 Million |
-12.39% |
| 2014-12-31 | CN¥424.27 Million ≈ $62.08 Million |
+82.46% |
| 2013-12-31 | CN¥232.53 Million ≈ $34.03 Million |
+24.66% |
| 2012-12-31 | CN¥186.54 Million ≈ $27.30 Million |
-3.54% |
| 2011-12-31 | CN¥193.39 Million ≈ $28.30 Million |
-- |
About Maccura Biotechnology Co Ltd
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such a… Read more